Peritoneal carcinomatosis of colorectal cancer: incidence, prognosis, and treatment modalities

C Knorr, B Reingruber, T Meyer… - International journal of …, 2004 - Springer
Background and aims Intraperitoneal carcinomatosis accounts for 25–35% of recurrences of
colorectal cancer. Studies demonstrate that peritoneal carcinomatosis is not necessarily a
terminal condition with no options for treatment or cure. Results The combination of
aggressive cytoreductive surgery and intra-abdominal hyperthermia chemotherapy
improves long-term overall survival in selected patients but is a time-consuming procedure
(approx. 12 h) and entails high mortality (5%) and morbidity (35%)). Most commonly used …

Peritoneal carcinomatosis of colorectal cancer: novel clinical and molecular outcomes

D Massalou, E Benizri, A Chevallier… - The American Journal of …, 2017 - Elsevier
Background The objective of this study was to identify the prognostic impact of parameters in
peritoneal carcinomatosis from colorectal cancer. Methods We collected data from patients
treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy for
peritoneal carcinomatosis secondary to colorectal cancer. Results Ninety-one procedures
were performed. In univariate analysis, an increased peritoneal cancer index was
associated with decreased survival (P<. 001). The presence of signet ring cells was …
以上显示的是最相近的搜索结果。 查看全部搜索结果